Stevens Capital Management LP Bristol Myers Squibb CO Transaction History
Stevens Capital Management LP
- $250 Million
- Q4 2024
A detailed history of Stevens Capital Management LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stevens Capital Management LP holds 5,867 shares of BMY stock, worth $341,518. This represents 0.13% of its overall portfolio holdings.
Number of Shares
5,867
Previous 28,492
79.41%
Holding current value
$341,518
Previous $1.47 Million
77.48%
% of portfolio
0.13%
Previous 0.21%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,752Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.1 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.24 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.59 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.54 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.51 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $124B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...